Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $21 | $22 | $24 | $21 |
| % Growth | -2.5% | -6.8% | 12.3% | – |
| Cost of Goods Sold | $13 | $12 | $13 | $12 |
| Gross Profit | $9 | $10 | $10 | $9 |
| % Margin | 40.5% | 47.6% | 42.9% | 44% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $2 | $2 | $0 |
| SG&A Expenses | $6 | $5 | $5 | $5 |
| Sales & Mktg Exp. | $4 | $3 | $3 | $0 |
| Other Operating Expenses | $0 | $5 | $0 | $0 |
| Operating Expenses | $6 | $10 | $7 | $5 |
| Operating Income | $3 | $0 | $3 | $4 |
| % Margin | 14.3% | 0.1% | 14.8% | 20.4% |
| Other Income/Exp. Net | -$6 | $3 | -$2 | -$1 |
| Pre-Tax Income | -$3 | $3 | $1 | $3 |
| Tax Expense | $0 | $1 | $0 | $1 |
| Net Income | -$3 | $2 | $1 | $2 |
| % Margin | -16.2% | 10.9% | 4.4% | 10.9% |
| EPS | -7.82 | 5.38 | 2.35 | 5.09 |
| % Growth | -245.4% | 128.9% | -53.8% | – |
| EPS Diluted | -7.82 | 5.38 | 2.35 | 5.09 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $0 | $1 |
| EBITDA | -$2 | $5 | $6 | $5 |
| % Margin | -10.5% | 22.5% | 24.9% | 24.9% |